{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:14:02Z","timestamp":1790802842964,"version":"4.1.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Ethambutol, one of four drugs in the first-line antitubercular regimen, is used to protect against rifampin resistance in the event of preexisting resistance to isoniazid. The population pharmacokinetics of ethambutol in South African patients with pulmonary tuberculosis were characterized using nonlinear mixed-effects modeling. Patients from 2 centers were treated with ethambutol (800 to 1,500 mg daily) combined with standard antitubercular medication. Plasma concentrations of ethambutol were measured following multiple doses at steady state and were determined using a validated high-pressure liquid chromatography-tandem mass spectrometric method. The data comprised 189 patients (54% male, 12% HIV positive) weighing 47 kg, on average (range, 29 to 86 kg), and having a mean age of 36 years (range, 16 to 72 years). The estimated creatinine clearance was 79 ml\/min (range, 23 to 150 ml\/min). A two-compartment model with one transit compartment prior to first-order absorption and allometric scaling by body weight on clearance and volume terms was selected. HIV infection was associated with a 15% reduction in bioavailability. Renal function was not related to ethambutol clearance in this cohort. Interoccasion variability exceeded interindividual variability for oral clearance (coefficient of variation, 36 versus 20%). Typical oral clearance in this analysis (39.9 liters\/h for a 50-kg individual) was lower than that previously reported, a finding partly explained by the differences in body weight between the studied populations. In summary, a population model describing the pharmacokinetics of ethambutol in South African tuberculosis patients was developed, but additional studies are needed to characterize the effects of renal function.<\/jats:p>","DOI":"10.1128\/aac.00274-11","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T05:21:42Z","timestamp":1308633702000},"page":"4230-4237","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":48,"title":["Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients"],"prefix":"10.1128","volume":"55","author":[{"given":"Siv","family":"J\u00f6nsson","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Davidse","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Wilkins","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"},{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Stefan","family":"Van der Walt","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"},{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika S. H.","family":"Simonsson","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"156","article-title":"Effect of food on ethambutol absorption","volume":"1","author":"Ameer B.","year":"1982","unstructured":"AmeerB. PolkR. E. KlineB. J. GrisafeJ. P.. 1982. Effect of food on ethambutol absorption. Clin. Pharm. 1:156\u2013158.","journal-title":"Clin. Pharm"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.167.4.603"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.24.25"},{"key":"e_1_3_2_5_2","volume-title":"NONMEM user's guides","author":"Beal S. L.","year":"1989","unstructured":"BealS. L. SheinerL. B. BoeckmannA. J.. 1989-2006. NONMEM user's guides. Icon Development Solutions, Ellicott City, MD."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1999.0526"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/599040"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/40.2.113"},{"key":"e_1_3_2_11_2","first-page":"1318","article-title":"Ethambutol dosage for the treatment of children: literature review and recommendations","volume":"10","author":"Donald P. R.","year":"2006","unstructured":"DonaldP. R. MaherD. MaritzJ. S. QaziS.. 2006. Ethambutol dosage for the treatment of children: literature review and recommendations. Int. J. Tuberc. Lung Dis. 10:1318\u20131330.","journal-title":"Int. J. Tuberc. Lung Dis"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.407-413.2006"},{"key":"e_1_3_2_13_2","unstructured":"HolfordN. 2005. The visual predictive check\u2014superiority to standard diagnostic (Rorschach) plots abstr. 738. Abstr. Population Approach Group in Europe 14. http:\/\/www.page-meeting.org\/?abstract=738."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/009127008702700113"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-2607(98)00067-4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01113502"},{"key":"e_1_3_2_17_2","unstructured":"KarlssonM. O.\nHolfordN.. 2008. A tutorial on visual predictive checks abstr 1434. Abstr. Population Approach Group in Europe 17. http:\/\/www.page-meeting.org\/?abstract=1434."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544030-00001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977225part1615"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01059382"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2003.11.003"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2005.04.005"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1170-1177.2006"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(1998)78:11 <48::AID-IJC14>3.0.CO;2-3"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0851-0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1965.91.1.51"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000901"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.3.568"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/498024"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-010-0304-x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00447-09"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-007-9066-0"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9133-0"},{"key":"e_1_3_2_34_2","first-page":"34","article-title":"Ethambutol kinetics in patients with impaired renal function","volume":"134","author":"Varughese A.","year":"1986","unstructured":"VarugheseA. BraterD. C. BenetL. Z. LeeC. S.. 1986. Ethambutol kinetics in patients with impaired renal function. Am. Rev. Respir. Dis. 134:34\u201338.","journal-title":"Am. Rev. Respir. Dis"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5309.122"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5420.1677"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-07"},{"key":"e_1_3_2_38_2","volume-title":"Ethambutol efficacy and toxicity: literature review and recommendations for daily and intermittent dosage in children","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. 2006. Ethambutol efficacy and toxicity: literature review and recommendations for daily and intermittent dosage in children. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_39_2","volume-title":"Treatment of tuberculosis: guidelines","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. 2010. Treatment of tuberculosis: guidelines, 4th ed. World Health Organization, Geneva, Switzerland.","edition":"4"},{"key":"e_1_3_2_40_2","first-page":"1360","article-title":"Pharmacokinetics of ethambutol in children and adults with tuberculosis","volume":"8","author":"Zhu M.","year":"2004","unstructured":"ZhuM. . 2004. Pharmacokinetics of ethambutol in children and adults with tuberculosis. Int. J. Tuberc. Lung Dis. 8:1360\u20131367.","journal-title":"Int. J. Tuberc. Lung Dis"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00274-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00274-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:25:30Z","timestamp":1645485930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00274-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1128\/AAC.00274-11"],"URL":"https:\/\/doi.org\/10.1128\/aac.00274-11","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"2011-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}